title: Cholesterol embolization syndrome following thrombolytic therapy with streptokinase and tissue plasminogen activator.
authors.affiliation: Dept. of Internal Medicine B, Meir General Hospital, Kfar Saba, Israel.
authors.forename: S
authors.initials: S
authors.lastname: Ben-Chitrit
authors.forename: Z
authors.initials: Z
authors.lastname: Korzets
authors.forename: R
authors.initials: R
authors.lastname: Hershkovitz
authors.forename: J
authors.initials: J
authors.lastname: Bernheim
authors.forename: M
authors.initials: M
authors.lastname: Schneider
authors.forename: J
authors.initials: J
authors.lastname: Bernheim
mesh_terms: D000368:Aged; D017700:Embolism, Cholesterol / Q000139:chemically induced*; D005260:Female; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy; D013300:Streptokinase / Q000009:adverse effects*; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects*
chemical_list: D013300:Streptokinase; D010959:Tissue Plasminogen Activator